share_log

3 Penny Stocks Insiders Are Buying

3 Penny Stocks Insiders Are Buying

3便士股內部人士正在買入
Benzinga Real-time News ·  2021/08/06 21:06

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

當內部人士買賣股票時,這表明了他們對公司前景的信心或擔憂。對細價股感興趣的投資者和交易員可以在他們的整體投資或交易決策中考慮到這一點。

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

下面是最近一些值得注意的細價股內幕交易。有關更多信息,請查看Benzinga的內幕交易站台。

Mustang Bio

野馬生物

The Trade: Mustang Bio, Inc. (NASDAQ:MBIO) President and CEO Manuel Litchman acquired a total of 86206 shares shares at an average price of $2.91. The insider spent $250,859.46 to buy those shares.

“貿易”(The Trade): 野馬生物公司(納斯達克股票代碼:mBio)總裁兼首席執行官曼努埃爾·利奇曼共收購86206股股票均價為2.91美元。這位內部人士花了250,859.46美元購買了這些股票。

What’s Happening: The European Medicines Agency recently granted Priority Medicines designation to Mustang Bio’s MB-107 for X-linked severe combined immunodeficiency (X-SCID) in newly diagnosed infants, also known as bubble boy disease.

發生了什麼事?:歐洲藥品管理局(European Medicines Agency)最近向野馬生物公司(Mustang Bio)的MB-107授予了優先藥品稱號,用於治療新診斷嬰兒的X連鎖嚴重聯合免疫缺陷(X-SCID),也稱為泡沫症。

What Mustang Bio Does: Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on the acquisition, development, and commercialization of novel cancer immunotherapy products designed to utilize the power of the patient's own immune system to eliminate cancer cells.

野馬生物公司是做什麼的?野馬生物公司(Mustang Bio Inc)是一家臨牀階段的生物製藥公司,專注於新型癌症免疫療法產品的收購、開發和商業化,旨在利用患者自身免疫系統的力量來消除癌細胞。

Amergent Hospitality

美國式招待

The Trade: Amergent Hospitality Group, Inc. (OTC:AMHG) President Frederick L Glick acquired a total of 50000 shares at an average price of $0.47. To acquire these shares, it cost $23,500.00.

“貿易”(The Trade): 美國酒店集團(amergent Hotitality Group,Inc.)(場外交易:AMHG)總裁弗雷德裏克·L·格利克(Frederick L Glick)共收購50000股平均價格為0.47美元。收購這些股票的成本為23,500.00美元。

What’s Happening: Amergent Hospitality shares dropped more than 9% over the previous month.

發生了什麼事?:amergent Hotel的股價比前一個月下跌了9%以上。

What Amergent Hospitality Does: Amergent Hospitality Group Inc owns, operates, and franchises restaurant brands.

美式酒店業是做什麼的?:amergent Hotitality Group Inc.擁有、運營和特許經營餐飲品牌。

Emmaus Life Sciences

埃馬烏斯生命科學

The Trade: Emmaus Life Sciences, Inc. (OTC:EMMA) Chairman and CEO Yutaka Niihara acquired a total of 7600 shares shares at an average price of $1.48. The insider spent $11,248.00 to buy those shares.

“貿易”(The Trade): 埃馬烏斯生命科學公司(Emmaus Life Science,Inc.)(場外交易:Emma)董事長兼首席執行官新原裕隆(Yutaka Niihara)共收購7600股股票均價為1.48美元。這位內部人士花了11,248.00美元購買了這些股票。

What’s Happening: Emmaus Life Sciences shares jumped more than 14% since the start of the year.

發生了什麼事?:Emmaus生命科學公司股價自年初以來躍升逾14%。

What Emmaus Life Sciences Does: Emmaus Life Sciences Inc is a biopharmaceutical company engaged in the discovery, development, and commercialization of new treatments and therapies primarily for rare and orphan diseases.

埃馬烏斯生命科學是做什麼的:Emmaus生命科學公司是一家生物製藥公司,主要從事罕見和孤兒疾病的新療法和療法的發現、開發和商業化。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論